Status:
COMPLETED
Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand
Lead Sponsor:
AstraZeneca
Conditions:
Dyslipidemia
Eligibility:
All Genders
20-80 years
Brief Summary
The first phase of the study is a hospital-based cross-sectional, epidemiological survey. The required sample size is 1,260 patients from 50 hospitals across Thailand. Each of the hospital will enroll...
Eligibility Criteria
Inclusion
- Evidence of high cardiovascular risk
- Dyslipidemic currently being treated with the same therapy for at least 3 months
Exclusion
- Recent major trauma(within 12 weeks)
- Recent surgery requiring anesthesia including coronary bypass graft(within 12 weeks)
- Acute or abrupt change(within 1 month) in usual diet
- Pregnancy, breast-feeding currently, or postpartum within the last 6 months
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
1240 Patients enrolled
Trial Details
Trial ID
NCT00684151
Start Date
April 1 2008
End Date
November 1 2011
Last Update
December 12 2011
Active Locations (49)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Kannayao, Bangkok, Thailand
2
Research Site
Maung, Changwat Ang Thong, Thailand
3
Research Site
Maung, Changwat Chachoengsao, Thailand
4
Research Site
Maung, Changwat Chai Nat, Thailand